Graus, J. (Javier)
- Publications
- item.page.relationships.isContributorAdvisorOfPublication
- item.page.relationships.isContributorOfPublication
Search Results
Now showing 1 - 1 of 1
- Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients(Elsevier, 2021) Castells, L. (Lluis); Lladó, L. (Laura); Muñoz-Serrano, A. (Alejandro); García-Pajares, F. (Fernando); Otero, A. (Alejandra); González-Grande, R. (Rocío); Caballero, A. (Aránzazu); Graus, J. (Javier); Blanco-Fernández, G. (Gerardo); Fábrega, E. (Emilio); Navasa, M. (Miquel); González-Dieguez, M.L. (María Luisa); Cachero, A. (Alba); Bustamante-Schneider, J. (Javier); Rodriguez, M. (Manuel); Iñarrairaegui, M. (Mercedes); Arias-Milla, A. (Ana); Hierro, L. (Loreto); Vinaixa, C. (Carmen); Fondevila, C. (Constantino); Loinaz, C. (Carmelo); Nogueras, F. (Flor); Salcedo, M. (Magdalena); Ramírez, P. (Pablo); Colmenero, J. (Jordi); Pascual, S. (Sonia); Fernández-Yunquera, A. (Ainhoa); Álamo, J.M. (José María); Nuño, J. (Javier); Gastaca, M. (Mikel)In liver transplant patients, chronic immunosuppression increases the risk of acquiring COVID-19 but it could reduce disease severity. Com- plete immunosuppression with- drawal may not be justified. However, mycophenolate withdrawal or tem- porary conversion to calcineurin inhibitors or everolimus until disease resolution could be beneficial in hos- pitalised patients.